UGITF 1995 (Best Exhibitor of Pharmaceuticals).
Frost and Sullivan 2010
Frost and Sullivan 2010 (Uganda Health Care Industry – Product Leadership of the Year Award)
CSR Exemplary Award
CSR Exemplary Award (Uganda Chapter for Corporate Social Responsibility Initiatives Ltd, UCCSRI)
Milestones & Achievements
In collaboration with WHO and the Ministry of Health launched ‘Homapak’ a sulfadoxine pyrimethamine + chloroquine combination therapy formulated in age-specific single-use dosage packs for children between the age of 2 months and 5 years. This has been the flagship brand in the Home Based Management of Fever strategy launched in the same year which resulted in an increase in children receiving treatment within 24 hours from 7.3% in 2001 to 55% nationally by the year 2005.
First to Locally manufacture and launch an Artemesinin Combination Treatment called Duact (Artesunate + Amodiaquine) in Uganda.
Commenced contract manufacturing of anti-malarials and injectables
Commissioned a Formulation Development Laboratory equipped with stability chambers for accelerated and real time stability studies (First in Uganda)
Commenced contract packaging of Medical diagnostic devices and reagents.
Launched the first Diabetic drug manufactured in Uganda: Formin (Metformin Hcl) for treatment of Type II Diabetes Mellitus.
Launched the first Anti-hypertensive manufactured in Uganda: Cardipac (Amlodipine)
Launched our official Code of Ethics, “Producing medicines with integrity”.
Umbigel an antiseptic for umblical cords
Registered Kamadol plus